39 John F. Kennedy St, Cambridge, MA 02138
Apnimed, Inc. is incorporated in Delaware.
Apnimed, Inc. was founded in 2017.
Apnimed, Inc.’s shares are traded on the Nasdaq Global Market under the symbol APMD.
Apnimed, Inc.'s initial public offering (IPO) occurred on July 31, 2026.
Apnimed, Inc.’s fiscal year ends on December 31.
Deloitte & Touche LLP
The CUSIP number for APMD is 03770Y107.
Shares of Apnimed, Inc.’s stock can be purchased by contacting a securities broker of your choice.
Apnimed, Inc. does not currently pay dividends or offer a stock reinvestment plan.
Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10043
(800) 937-5449
For questions about your stock please contact our transfer agent, Equiniti Trust Company, LLC.
Quarterly & Annual reports and other investor materials are available in the “Investors” section of Apnimed, Inc.’s corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Please click here to be directed to the email alerts page.
For investor inquiries, please send an email to ir@apnimed.com.